![]() |
Scientific organizers: Johan W. Mouton, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands & H. Derendorf, University of Florida, Gainesville, Fla. |
Pharmacokinetics and Pharmacodynamics (PK/PD) have now become essential tools for determining the appropriate use of currently available anti-infective agents as well as for accelerating the development of new drugs. While this is now more and more recognized by Academia, Industry and Regulatory Agencies (see the ISAP / FDA and ISAP / EMEA workshops held in 1999, there is presently a lack of training into these disciplines. Accordingly, ISAP has endeavoured to launch educational activities in this context. The aim is to train people professionally involved in development or in the use of antiinfective drugs in the basic and applied aspects of pharmacokinetics and pharmacodynamics, showing how these sciences have emerged over the last 10 years and how their influence has grown.
Since 1999, ISAP has organized
4 full-day educational workshops in association with ECCMID (1999, 2000,
2001) and ICAAC (2000) [see "Past
Educational Activities"]. Following specific demands, this 5th
educational workshop will be organized as two successive parts (half a
day each) dealing with the basic aspects of PK/PD and advanced studies,
respectively. Each part can be followed independently, but the two parts
can also be combined.
Objectives: The workshop has allowed the attendee to gain
Intended Audience: Medical microbiologists, infectious disease physicians, pharmacologists, pharmacists and anybody else interested
Level:
Beginning
| Introduction to Pharmacokinetics and Pharmacodynamics | ||
| The general concept of pharmacokinetics:
|
H. Derendorf,
Department of Pharmaceutics, University of Florida, Gainsville, FL |
|
| Antimicrobial pharmacokinetics: lessons
learned from animal models:
Antimicrobial pharmacodynamics in animal models and use of pharmacodynamic parameters |
W.A. Craig,
Division of Infectious Diseases, University of Wisconsin, Madison, WI |
|
| Exercises and Discussion | J.W. Mouton &
H. Derendorf |
|
| Special topics | ||
| Protein binding, tissue concentrations : do they matter ? | O. Cars,
Division of Infectious Diseases, University Hospital, Uppsala, Sweden |
|
| Pharmacodynamics : implications therapy | J. Mouton,
Canisius Wilhelmina Hospital, Nijmegen, The Netherlands |
|
| Exercise and Discussion | J.W. Mouton &
H. Derendorf |
|
| Part 2: | Advanced
Issues in Pharmacodynamics:
PK/PD Modeling and Clinical Implications |
This second intermediate/advanced level, workshop has exapanded the attendee's focus on PK/PD modeling. The course has developped the use and application of Emax and other models, and has demonstrated how PK/PD models may be applied to in vitro, animal, and clinical problems. The workshop has also discussed the limitations of PK/PD models used with in vitro studies.
Intended Audience: Microbiologists, infectious disease physicians, pharmacologists, pharmacists and anybody else interested
Level: Intermediate/Advanced
| Concentration-effect relationships | ||
| General concepts of PK/PD modelling: types of models Linear models, non-linear models, Emax models, kill curve fitting | H. Derendorf,
Department of Pharmaceutics, University of Florida, Gainsville, FL |
|
| In-vitro models of infection | I. Odenholt, MD
Departement of Infectious Diseases, Malmö University Hospital, Malmö, Sweden |
|
| Exercise and Discussion | J.W. Mouton &
H. Derendorf |
|
| Use of concentration-effect relationships and exercises | ||
| Animal models of infection | W.A. Craig,
Division of Infectious Diseases, University of Wisconsin, Madison, WI |
|
| Clinical Implications of Pk/PD modelling | J. Mouton,
Canisius Wilhelmina Hospital, Nijmegen, The Netherlands |
|
| Excercises and Discussion | J.W. Mouton &
H. Derendorf |
|